How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Polman, C., O'Connor, P., Havrdová, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J., Lublin, F., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,293

Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

Yednock, T. A., Cannon, C., Fritz, L. C., Sánchez‐Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E. E., Garren, H., Langer-Gould, A. M., Strober, S., Cannella, B., Allard, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,659

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E. E., Baumruker, T., HIESTAND, P. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,512

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Rudick, R. A., Stuart, W. H., Calabresi, P. A., Confavreux, C., Galetta, S. L., Radue, E. W., LUBLIN, F. D., Weinstock‐Guttman, B., Wynn, D. R., Lynn, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044396 · Cited by 1,342

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,096

TNF neutralization in MS

The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,068

The T Lymphocyte In Experimental Allergic Encephalomyelitis

Zamvil, S. S., & Steinman, L. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003051 · Cited by 1,013

Substrain Differences Reveal Novel Disease-Modifying Gene Candidates That Alter the Clinical Course of a Rodent Model of Multiple Sclerosis

deLuca, L. S., Pikor, N. B., O’Leary, J., Galicia, G., Ward, L. A., Defreitas, D., Finlay, T. M., Ousman, S. S., Osborne, L. R., & Gommerman, J. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902881 · Cited by 31

Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin

Rodriguez, M., Wootla, B., & Anderson, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160915160520 · Cited by 32

Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice – A step towards understanding the complexity of multiple sclerosis

Kuerten, S., & Angelov, D. N. (2008) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2007.11.001 · Cited by 40

Mechanism of oxidative stress p38MAPK-SGK1 signaling axis in experimental autoimmune encephalomyelitis (EAE)

Wang, L., Li, B., Quan, M., Li, L., Chen, Y., Tan, G.-J., Zhang, J., Liu, X., & Guo, L. (2017) · Oncotarget · doi:10.18632/oncotarget.17057 · Cited by 31

Specific and Strain-Independent Effects of Dexamethasone in the Prevention and Treatment of Experimental Autoimmune Encephalomyelitis in Rodents

Donia, M., Mangano, K., Quattrocchi, C., Fagone, P., Signorelli, S. S., Magro, G. G., Sfacteria, A., Bendtzen, K., & Nicoletti, F. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02451.x · Cited by 31

Dendritic Cells and Multiple Sclerosis: Disease, Tolerance and Therapy

Mohammad, M. G., Hassanpour, M., Tsai, V. W.-W., Li, H., Ruitenberg, M. J., Booth, D. R., Serrats, J., Hart, P. H., Symonds, G., Sawchenko, P. E., et al. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010547 · Cited by 34

Tissue concentration changes of amino acids and biogenic amines in the central nervous system of mice with experimental autoimmune encephalomyelitis (EAE)

Musgrave, T., Tenorio, G., Rauw, G. A., Baker, G. B., & Kerr, B. J. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.03.020 · Cited by 30

Immunopathogenesis of multiple sclerosis: concepts and controversies

Holmøy, T. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00845.x · Cited by 30

Sildenafil ameliorates EAE by decreasing apoptosis in the spinal cord of C57BL/6 mice

Duarte-Silva, E. P., Araújo, S. M. D. R., de Oliveira, W. H., Lós, D. B., de França, M. E. R., Bonfanti, A. P., Peron, G., Thomaz, L. D. L., Verinaud, L. M. C., Nunes, A. K. S., et al. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.002 · Cited by 30

Humanized mouse models for organ-specific autoimmune diseases

Friese, M. A., Jensen, L. T., Willcox, N., & Fugger, L. H. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.003 · Cited by 30

Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?

Cavone, L., & Chiarugi, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.10.002 · Cited by 29

Blockade of Experimental Multiple Sclerosis by Inhibition of the Acid Sphingomyelinase/Ceramide System

Becker, K. A., Halmer, R., Davies, L., Henry, B., Ziobro, R., Decker, Y., Liu, Y., Gulbins, E., Fassbender, K. C., & Walter, S. (2017) · Neurosignals · doi:10.1159/000484621 · Cited by 29

Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis

Hollinger, K. R., Alt, J., Riehm, A., Slusher, B. S., & Kaplin, A. I. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.035 · Cited by 29

Rotarod motor performance and advanced spinal cord lesion image analysis refine assessment of neurodegeneration in experimental autoimmune encephalomyelitis

van den Berg, R., Laman, J. D., van Meurs, M., Hintzen, R. Q., & Hoogenraad, C. C. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.01.013 · Cited by 30

Identification of a B cell-dependent subpopulation of multiple sclerosis by measurements of brain-reactive B cells in the blood

Küerten, S., Pommerschein, G., Barth, S. K., Hohmann, C., Milles, B., Sammer, F. W., Duffy, C. E., Wunsch, M., Rovituso, D. M., Schroeter, M., et al. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.02.014 · Cited by 28

Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination

Loda, E., & Balabanov, R. D. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2011-068 · Cited by 28

Novel insights into the mechanisms underlying depression-associated experimental autoimmune encephalomyelitis

Duarte-Silva, E. P., Macêdo, D. S., Maes, M. H. J., & Peixoto, C. A. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.03.001 · Cited by 29

IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination

Ren, Z., Wang, Y., Liebenson, D., Liggett, T., Goswami, R., Stefoski, D., & Balabanov, R. D. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.01.001 · Cited by 27

Experimental autoimmune encephalomyelitis (EAE) IN C57Bl/6 mice is not associated with astrogliosis

Pham, H., Doerrbecker, J., Ramp, A. A., D'Souza, C. S., Gorasia, D. G., Purcell, A. W., Ayers, M. M., & Orian, J. M. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.006 · Cited by 27

Splenic natural killer cell activity in two models of experimental neurodegenerative diseases

Al‐Falahi, Y., Sand, K. L., Knudsen, E., Damaj, B. B., Rolin, J., & Maghazachi, A. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00640.x · Cited by 26

A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis

Pasquali, L., Lucchesi, C., Pecori, C., Metelli, M. R., Pellegrini, S., Iudice, A., & Bonuccelli, U. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.12.005 · Cited by 27

Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling

Abdel-Maged, A. E.-S., Gad, A. M., Rashed, L. A., Azab, S. S., Mohamed, E. A., & Awad, A. S. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01972-9 · Cited by 29

Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective

Nishihara, H., & Engelhardt, B. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_407 · Cited by 27

Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica

Yang, T., Wang, S., Zheng, Q., Wang, L., Li, Q., Wei, M., Du, Z., & Fan, Y. (2016) · BMC Neurology · doi:10.1186/s12883-016-0622-3 · Cited by 25

P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice

Zhang, W., Liu, M., Liu, Y., Huang, F., Lan, Y., Li, H., Wu, H., Zhang, B., Shi, H., & Wu, X. (2019) · Molecules · doi:10.3390/molecules24030561 · Cited by 25

Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: Peripheral versus in situ immunoregulation

Bynoe, M. S., Bonorino, P., & Viret, C. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.010 · Cited by 25

Arachidonyl trifluoromethyl ketone ameliorates experimental autoimmune encephalomyelitis via blocking peroxynitrite formation in mouse spinal cord white matter

Vana, A. C., Li, S., Ribeiro, R., Tchantchou, F., & Zhang, Y. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.05.014 · Cited by 24

Direct and consensual murine pupillary reflex metrics: Establishing normative values

Hussain, R. Z., Hopkins, S. C., Frohman, E. M., Eagar, T. N., Cravens, P. D., Greenberg, B. M., Vernino, S. A., & Stüve, O. (2009) · Autonomic Neuroscience · doi:10.1016/j.autneu.2009.07.021 · Cited by 24

Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice

Zayoud, M., Malki, K., Frauenknecht, K., Trinschek, B., Kloos, L., Karram, K., Wanke, F., Georgescu, J., Hartwig, U., Sommer, C., et al. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9466-4 · Cited by 24

Nanomaterial Applications in Multiple Sclerosis Inflamed Brain

Ballerini, C., Baldi, G., Aldinucci, A., & Maggi, P. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9588-y · Cited by 24

Multiple sclerosis pathogenesis: missing pieces of an old puzzle

Rahmanzadeh, R., Brück, W., Minagar, A., & Sahraian, M. A. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0002 · Cited by 28

Neuroimaging of demyelination and remyelination models.

Pirko, I., & Johnson, A. J. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-73677-6_10 · Cited by 22

Human embryonic stem cells: An experimental and therapeutic resource for neurological disease

Joannides, A. J., & Chandran, S. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.09.008 · Cited by 24

Cellular Approaches for Stimulating CNS Remyelination

Miller, R. H., & Bai, L. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.5.817 · Cited by 24

The clinical course of EAE is reflected by the dynamics of the neuroantigen-specific T cell compartment in the blood

Küerten, S., Rottlaender, A., Rodi, M., Velasco, V. B., Schroeter, M., Kaiser, C., Addicks, K., Tary‐Lehmann, M., & Lehmann, P. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.09.004 · Cited by 23

Autoimmunity and inflammation: murine models and translational studies

Hall, S. W., & Cooke, A. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9338-2 · Cited by 23

NMR and Pattern Recognition Can Distinguish Neuroinflammation and Peripheral Inflammation

Smolinska, A., Attali, A., Blanchet, L., Ampt, K. A. M., Tuinstra, T., van Aken, H. H. M., Suidgeest, E., van Gool, A. J., Luider, T. M., Wijmenga, S. S., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200203v · Cited by 23

Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists

Lange, J. H. M., Attali, A., van der Neut, M. A. W., Wals, H. C., Mulder, A. T., Zilaout, H., Duursma, A., van Aken, H. H. M., & Vliet, B. J. V. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.056 · Cited by 23

Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis

Fiander, M. D. J., Stifani, N., Nichols, M. T., Akay, T., & Robertson, G. S. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.09.034 · Cited by 23

Laquinimod enhances central nervous system barrier functions

Lühder, F., Kébir, H., Odoardi, F., Litke, T., Sonneck, M., Alvarez, J. I., Winchenbach, J., Eckert, N., Hayardeny, L., Sorani, E., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.002 · Cited by 23

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis

Sotelo, J., & Corona, T. (2011) · Multiple Sclerosis International · doi:10.1155/2011/214763 · Cited by 23

Increased Transcriptional Activity of Milk-Related Genes following the Active Phase of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis1

Otaegui, D., Mostafavi, S., Bernard, C., de Munain, A. L., Mousavi, P., Oksenberg, J., & Baranzini, S. (2007) · Journal of Immunology · doi:10.4049/jimmunol.179.6.4074 · Cited by 23

Cognitive Impairment in Neurological Diseases: Lessons from Apolipoprotein E

Shi, J., Han, P., & Kuniyoshi, S. M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130623 · Cited by 22

Human amniotic epithelial cells suppress relapse of corticosteroid-remitted experimental autoimmune disease

Liu, Y.-H., Chan, J. M. K., Vaghjiani, V., Murthi, P., Manuelpillai, U., & Toh, B. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2013.10.007 · Cited by 22

Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE

Hu, X., Tomlinson, S., & Barnum, S. R. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.012 · Cited by 22

Neuropathic Pain in Multiple Sclerosis and Its Animal Models: Focus on Mechanisms, Knowledge Gaps and Future Directions

Mirabelli, E., & Elkabes, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.793745 · Cited by 23

Effect of oral genistein administration in early and late phases of allergic encephalomyelitis.

Jahromi, S. R., Arrefhosseini, S. R., Ghaemi, A., Alizadeh, A., Sabetghadam, F., & Togha, M. (2014) · PubMed Central · Cited by 22

Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency

Frausto, R. F., Crocker, S. J., Eam, B., Whitmire, J. K., & Whitton, J. L. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.024 · Cited by 22

Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity

Hertzenberg, D., Lehmann‐Horn, K., Häusser‐Kinzel, S., Husterer, V., Cravens, P. D., Kieseier, B. C., Hemmer, B., Brück, W., Zamvil, S. S., Stüve, O., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201343338 · Cited by 22

Glatiramer acetate therapy for multiple sclerosis: a review

Perumal, J. S., Filippi, M., Ford, C. C., Johnson, K. P., Lisak, R. P., Metz, L. M., Tselis, A. C., Tullman, M. J., & Khan, O. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.1019 · Cited by 22

p38 MAP Kinase Signaling in Microglia Plays a Sex-Specific Protective Role in CNS Autoimmunity and Regulates Microglial Transcriptional States

McGill, M. M., Richman, A. R., Boyd, J. R., Sabikunnahar, B., Lahue, K. G., Montgomery, T. L., Caldwell, S. K., Varnum, S., Frietze, S. E., & Krementsov, D. N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715311 · Cited by 23

Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care

Einstein, O., Katz, A., & Ben‐Hur, T. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103033 · Cited by 21

Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis

Soellner, I. A., Rabe, J. L., Mauri, V., Kaufmann, J., Addicks, K., & Küerten, S. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.10.011 · Cited by 21

Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE

Levy‐Barazany, H., Barazany, D., Puckett, L. L., Blanga‐Kanfi, S., Borenstein‐Auerbach, N., Yang, K., Peron, J. P. S., Weiner, H. L., & Frenkel, D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.02.010 · Cited by 23

Ascomycete derivative to MS therapeutic: S1P receptor modulator FTY720

HIESTAND, P. C., Rausch, M., Meier, D. P., & Foster, C. A. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8595-8_8 · Cited by 21

Autoimmune Versus Oligodendrogliopathy: The Pathogenesis of Multiple Sclerosis

Nakahara, J., Aiso, S., & Suzuki, N. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0094-x · Cited by 21

A Soluble Epoxide Hydrolase Inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis

Jonnalagadda, D., Wan, D., Chun, J. J. M., Hammock, B. D., & Kihara, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094650 · Cited by 21

Roles of prostaglandins in immunosuppression

Luo, M., He, N., Xu, Q. R., Wen, Z., Wang, Z., Zhao, J., & Liu, Y. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110298 · Cited by 20

Nicotinic Acid‐Mediated Activation of Both Membrane and Nuclear Receptors towards Therapeutic Glucocorticoid Mimetics for Treating Multiple Sclerosis

Penberthy, W. T. (2009) · PPAR Research · doi:10.1155/2009/853707 · Cited by 20

Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitis

Theotokis, P., Kleopa, K. A., Touloumi, O., Lagoudaki, R., Lourbopoulos, A. I., Nousiopoulou, E., Kesidou, E., Poulatsidou, K.-N., Dardiotis, E., Hadjigeorgiou, G. M., et al. (2015) · Glia · doi:10.1002/glia.22843 · Cited by 20

The flavonoid-enriched fraction AF4 suppresses neuroinflammation and promotes restorative gene expression in a mouse model of experimental autoimmune encephalomyelitis

Warford, J. R., Jones, Q. R. D., Nichols, M. T., Sullivan, V., Rupasinghe, H. P. V., & Robertson, G. S. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.01.007 · Cited by 19

Chronic autoimmune-mediated inflammation: a senescent immune response to injury

Hart, B. A. ‘., Chalan, P., Koopman, G., & Boots, A. M. H. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.11.010 · Cited by 20

S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells

Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Al‐Mazroua, H. A., Alomar, H. A., Al‐Hamamah, M. A., & Attia, S. M. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104658 · Cited by 19

High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro

Soldati, S. G., Bär, A., Vladymyrov, M., Glavin, D., McGrath, J. L., Gosselet, F., Nishihara, H., Goelz, S. E., & Engelhardt, B. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02797-8 · Cited by 23

Therapeutic Efficacy of Erythropoietin in Experimental Autoimmune Encephalomyelitis in Mice, a Model of Multiple Sclerosis

Cervellini, I., Ghezzi, P., & Mengozzi, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-308-4_10 · Cited by 19

Stem cell-derived neurotrophic support for the neuromuscular junction in spinal muscular atrophy

Wyatt, T. J., & Keirstead, H. S. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.529895 · Cited by 18

Novel approaches for identifying target antigens of autoreactive human B and T cells

Dornmair, K., Meinl, E., & Hohlfeld, R. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0179-y · Cited by 19

Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL

Prinz-Hadad, H., Mizrachi, T., Irony-Tur-Sinai, M., Prigozhina, T. B., Aronin, A., Brenner, T., & Dranitzki-Elhalel, M. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-36 · Cited by 19

Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis

Baranzini, S. E. (2006) · Autoimmunity · doi:10.1080/08916930601061686 · Cited by 18

Magnetic resonance imaging of experimental autoimmune encephalomyelitis in the common marmoset

Maggi, P., Sati, P., & Massacesi, L. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.09.016 · Cited by 20

Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis

Iannitti, T., Kerr, B. J., & Taylor, B. K. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_288 · Cited by 19

Early handling increases susceptibility to experimental autoimmune encephalomyelitis (EAE) in C57BL/6 male mice

Cabezas, S. C., Iaffaldano, G., Chiarotti, F., Alleva, E., & Cirulli, F. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.05.007 · Cited by 19

p38MAPK/SGK1 signaling regulates macrophage polarization in experimental autoimmune encephalomyelitis

Li, B., Tan, T.-B., Wang, L., Zhao, X.-Y., & Tan, G.-J. (2019) · Aging · doi:10.18632/aging.101786 · Cited by 19

From defining antigens to new therapies in multiple sclerosis: Honoring the contributions of Ruth Arnon and Michael Sela

Steinman, L., & Shoenfeld, Y. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.08.001 · Cited by 18

Variation of genes encoding nitric oxide synthases and antioxidant enzymes as potential risks of multiple sclerosis development: a preliminary study

Wigner, P., Dziedzic, A., Synowiec, E., Miller, E. D., Bijak, M., & Saluk, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-14795-6 · Cited by 20

Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis

Dagley, L. F., Emili, A., & Purcell, A. W. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200104 · Cited by 19

Pioglitazone is superior to quetiapine, clozapine and tamoxifen at alleviating experimental autoimmune encephalomyelitis in mice

Chedrawe, M. A. J., Holman, S. P., Lamport, A.-C., Akay, T., & Robertson, G. S. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.001 · Cited by 20

Selective Vulnerability of Synaptic Signaling and Metabolism to Nitrosative Stress

Mongin, A. A., Dohare, P., & Jourd’heuil, D. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4559 · Cited by 19

The gray aspects of white matter disease in multiple sclerosis

Steinman, L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903377106 · Cited by 18

Minocycline Effects on the Cerebrospinal Fluid Proteome of Experimental Autoimmune Encephalomyelitis Rats

Stoop, M. P., Rosenling, T., Attali, A., Meesters, R. J. W., Stingl, C., Dekker, L. J. M., van Aken, H. H. M., Suidgeest, E., Hintzen, R. Q., Tuinstra, T., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300428e · Cited by 18

Transgenic mouse models of multiple sclerosis

Scheikl, T., Pignolet, B., Mars, L. T., & Liblau, R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0481-9 · Cited by 18

GPX4 aggravates experimental autoimmune encephalomyelitis by inhibiting the functions of CD4+ T cells

Li, H., Zeng, Y., Luo, S., Li, Z., Huang, F., & Liu, Z. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.034 · Cited by 17

Hematopoietic Stem Cell Gene Therapy as a Treatment for Autoimmune Diseases

Alderuccio, F., Nasa, Z., Chung, J.-Y., Ko, H., Chan, J. M. K., & Toh, B. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2001523 · Cited by 17

Anti-MS4a4B treatment abrogates MS4a4B-mediated protection in T cells and ameliorates experimental autoimmune encephalomyelitis

Yan, Y., Li, Z., Zhang, G., Williams, M. S., Carey, G. B., Zhang, J., Rostami, A. M., & Xu, H. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0870-2 · Cited by 17

Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis

Cusick, M. F., Libbey, J. E., Oh, L. Y. S., Jordan, S., & Fujinami, R. S. (2014) · Autoimmunity · doi:10.3109/08916934.2014.984836 · Cited by 17

A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis

Trager, N., Butler, J. T., Harmon, J. L., Mount, J., Podbielska, M., Haque, A., Banik, N. L., & Beeson, C. C. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0739-4 · Cited by 16

MANF Is Neuroprotective in Early Stages of EAE, and Elevated in Spinal White Matter by Treatment With Dexamethasone

Nam, J. H., Koppinen, T. K., & Voutilainen, M. H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.640084 · Cited by 16

Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis

Xiao, J., Liu, W., Chen, Y., & Deng, W. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0338-0 · Cited by 16

Targeting Insulin-Like Growth Factor 1 Leads to Amelioration of Inflammatory Demyelinating Disease

Cusick, M. F., Libbey, J. E., Trede, N. S., & Fujinami, R. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094486 · Cited by 16

Discovery of Novel Disease-specific and Membrane-associated Candidate Markers in a Mouse Model of Multiple Sclerosis*

Dagley, L. F., Croft, N., Isserlin, R., Olsen, J. B., Fong, V., Emili, A., & Purcell, A. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.033340 · Cited by 12

Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination

Biswas, K., Chatterjee, D., Addya, S., Khan, R. S., Kenyon, L. C., Choe, A., Cohrs, R. J., Shindler, K. S., & Sarma, J. D. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.07.004 · Cited by 15

The Destructive Alliance: Interactions Of Leukocytes, Cerebral Endothelial Cells, and the Immune Cascade in Pathogenesis of Multiple Sclerosis

Minagar, A., Carpenter, A. C., & Alexander, J. S. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79001-3 · Cited by 16

Monoclonal antibody treatments for multiple sclerosis

ROSE, J. W., Foley, J. F., & Carlson, N. G. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0065-3 · Cited by 16

Effects of an aqueous extract of North American ginseng on MOG(35-55)-induced EAE in mice.

Bowie, L. E., Roscoe, W., Lui, E., Smith, R., & Karlik, S. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-092 · Cited by 14

Isolation and Initial Application of a Novel Peptide That Specifically Recognizes the Neural Stem Cells Derived from Rhesus Monkey Embryonic Stem Cells

Zhao, W., Yuan, H., Xu, X., & Ma, L. (2010) · SLAS DISCOVERY · doi:10.1177/1087057110370997 · Cited by 15

A novel CNS-homing peptide for targeting neuroinflammatory lesions in experimental autoimmune encephalomyelitis

Acharya, B., Meka, R. R., Venkatesha, S. H., Lees, J. R., Teesalu, T., & Moudgil, K. D. (2020) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2020.101530 · Cited by 15

Implication of Contactins in Demyelinating Pathologies

Kalafatakis, I., Savvaki, M., Velona, T., & Karagogeos, D. (2021) · Life · doi:10.3390/life11010051 · Cited by 16

Matrine downregulates IL-33/ST2 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis

Zhao, X., Zhang, X., Lv, Y., Xu, Y., Li, M., Qingxia, P., Chu, Y., Liu, N., Zhang, G., & Zhu, L. D. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.08.007 · Cited by 15

Proteomic strategies in multiple sclerosis and its animal models

Elkabes, S., & Li, H. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700315 · Cited by 16

Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug

Karpus, W. J., Reynolds, N., Behanna, H. A., Eldik, L. J. V., & Watterson, D. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.039 · Cited by 15

Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis

Sriram, S., & Steiner, I. (2005) · Annals of Neurology · doi:10.1002/ana.20743 · Cited by 265

Experimental Autoimmune Encephalomyelitis Model for Discovery of New Therapy for Multiple Sclerosis

Singhal, M., & Srivastava, P. (2012) · Cited by 1

The experimental autoimmune encephalomyelitis (EAE) model of MS

(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00008-x · Cited by 464

Experimental Allergic Encephalomyelitis as a Model of Multiple Sclerosis

Alvord, E. C. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0777-8_13

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 2005;58: 939–945

Sriram, S., & Steiner, I. (2015)